Toi Labs key facts
as of Oct 2026- Developer of an AI-powered toilet seat designed to continuously monitor health through biometrics and precision waste data that is used in senior care homes throughout the US.
- Toi Labs is valued at approximately $30.0M as of Oct 2026 (last reported valuation).
- It has raised $11.0M; the latest was Later Stage VC ($9.0M) in Jan 2025.
- Notable investors include National Institutes of Health, Scale Good Fund, Freestyle Capital, 3Lines, AgeTech Collaborative from AARP — 13 tracked in total.
- Status: Privately Held (backing).
Toi Labs's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Toi Labs: the Monday email on marks, rounds and moves
Toi Labs funding rounds
No funding rounds for Toi Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Toi Labs
13+Toi Labs valuation
Toi Labs's last reported valuation was $30 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
Toi Labs investors
13 investors are on record for Toi Labs, including National Institutes of Health, Scale Good Fund, Freestyle Capital and 3Lines.
About Toi Labs
Developer of an AI-powered toilet seat designed to continuously monitor health through biometrics and precision waste data that is used in senior care homes throughout the US. The company's toilet seat monitors output round the clock to provide insights into health and wellness to automate care and help to reduce the risk or impact of certain chronic lower digestive and urinary conditions, enabling seniors and older adults to detect any change in their health condition and take early precautions.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2018
- Employees
- 15
- Website
- toilabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.